New Findings Provide Additional Insights into the Management of Anaemia and Secondary Hyperparathyroidism in Chronic Kidney Disease Patients.
PR Newswire Europe, May, 2009
MILAN, May 25 /PRNewswire/ --
Data presented from large-scale observational studies provide new insights into the day-to-day management of two major complications of CKD: anaemia and secondary hyperparathyroidism (SHPT).(1), (2), (3), (4)
- CKD anaemia: Aranesp(R) (darbepoetin alfa) flexible dosing intervals
help maintain haemoglobin (Hb) levels within the target range for
dialysis and pre-dialysis patients, while offering the convenience of
extended dosing(1), (2), (3)
- SHPT: New European data show the importance of early initiation of
Mimpara(R) (cinacalcet) to achieve therapeutic targets in SHPT(4)
A nephrology pioneer for more than 20 years, Amgen presented at the World Congress of Nephrology...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics



